Considering the close relationship between apelin expression and profibrogenic factors in HSCs, and the alleviation of fibrogenesis and angiogenesis under the condition of APJ blockade in hepatic fibrosis, the apelin/APJ system might be a promising therapeutic target for liver fibrosis. The gene discussed is APLN; the disease is Hepatic fibrosis.